OptimizeRx Corporation
OPRX
$15.27
-$0.11-0.72%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 24.18% | 25.90% | 20.66% | 28.81% | 40.40% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 24.18% | 25.90% | 20.66% | 28.81% | 40.40% |
| Cost of Revenue | 15.17% | 17.84% | 10.84% | 14.42% | 30.40% |
| Gross Profit | 29.57% | 30.84% | 26.95% | 38.41% | 47.14% |
| SG&A Expenses | 3.18% | 2.48% | 6.48% | 14.06% | 12.63% |
| Depreciation & Amortization | 2.36% | 20.56% | 44.91% | 80.15% | 128.99% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.27% | 8.39% | 9.26% | 16.06% | 21.04% |
| Operating Income | 188.90% | 136.06% | 70.47% | 52.96% | 53.44% |
| Income Before Tax | 105.06% | 64.56% | 36.28% | 22.87% | -143.00% |
| Income Tax Expenses | 118.04% | 106.77% | 90.25% | 109.58% | -27,854.55% |
| Earnings from Continuing Operations | 100.14% | 44.91% | 14.71% | -14.48% | -75.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 100.14% | 44.91% | 14.71% | -14.48% | -75.81% |
| EBIT | 188.90% | 136.06% | 70.47% | 52.96% | 53.44% |
| EBITDA | 410.91% | 220.99% | 112.43% | 82.54% | 75.16% |
| EPS Basic | 100.11% | 46.40% | 18.36% | -7.51% | -64.13% |
| Normalized Basic EPS | 113.11% | 86.46% | 32.41% | 7.91% | 14.11% |
| EPS Diluted | 99.69% | 46.28% | 18.67% | -6.97% | -65.46% |
| Normalized Diluted EPS | 112.40% | 86.13% | 32.41% | 7.91% | 14.11% |
| Average Basic Shares Outstanding | 2.00% | 4.07% | 5.60% | 6.82% | 6.85% |
| Average Diluted Shares Outstanding | 3.91% | 4.78% | 5.60% | 6.82% | 6.85% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |